Loading...

CAMBIASO TELLS 60 MINUTES: “THEY ARE ALL CUARTETERA”

PoloChannel Staff | 03/12/18

 

 

On national television last night Adolfo Cambiaso set the record straight about his
cloning program. In a special episode of the CBS program 60 Minutes, interviewer
Lesley Stahl asked why his Cuartetera clones (officially known as “B01” through
“B14”) don’t have names. With the corners of his mouth slightly upturned and that
intense stare of his, he replied, “They have names.”


Stahl asks what B02’s name is.


AC: “Cuartetera.”


B04?


AC: “Cuartetera.”


B07? B10? B13 . . . ?


AC: “Cuartetera. They are all Cuartetera.”


Stahl wasn’t satisfied. “But twins have different names.”


AC: “These are not twins. They are clones.”


Click here to watch the entire episode:
https://www.cbsnews.com/news/the-clones- of-polo/


Thus begins a fascinating and educational behind-the- scenes look into Cambiaso’s
work with genetics pioneer Alan Meeker and Ernesto Gutierrez, his partners in
Crestview Genetics. Their cloning enterprise began more than a decade ago, and
they tell the story from the very beginning. The program flashes from interviews to
gut-wrenching close-up footage of a devastated Cambiaso walking off the polo field
after his prize stud, Aiken Cura, broke his leg during the Argentine Open and had to
be euthanized. He told the vet to save some of his cells in case it ever became
possible to clone a horse.
Along came Meeker, who made it not only a possibility but a reality. A polo player
who had long been fascinated with the idea of cloning polo ponies, he licensed the

technology and created Cambiaso’s first clone: Aiken Cura. Now they have more
than 100 clones.
Film footage, some of it produced by Horseplay Productions (horseplay.tv), brings
viewers into the these worlds and more:
- Crestview’s cloning operations in Argentina and South Carolina
- the “Cuartetera aisle” in Cambiaso’s stable
- Cambiaso playing a different Cuartetera clone in every chukker of the
Argentine Open final on his way to the win
- the scientific and ethical issues about cloning and its future